Orchestra BioMed Holdings (OBIO) Minority Interest (2025 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Minority Interest came in at $9.8 million in Q1 2026, little changed on a QoQ basis from $9.8 million in Q4 2025.
Orchestra BioMed Holdings (OBIO) Minority Interest (2025 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 2 years of Minority Interest data on file, last reported at $9.8 million in Q1 2026.
- On a quarterly basis, Minority Interest changed N/A year-over-year to $9.8 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $9.8 million, changed N/A from the prior year.
- Minority Interest for Q1 2026 stood at $9.8 million, roughly flat from $9.8 million in the prior quarter.
- Over the last five years, Minority Interest for OBIO reached as high as $9.8 million in Q4 2025 and fell as low as $9.8 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.77 Mn |
| Dec 31, 2025 | 9.81 Mn |